TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36690136

Group type: COMPARATOR
Intervention: Mild congestion (CCS ≤3)
Number of subjects: 3787

Group type: COMPARATOR
Intervention: Moderate congestion (CCS = 4 or 5)
Number of subjects: 3787

Group type: COMPARATOR
Intervention: Severe congestion (CCS ≥6)
Number of subjects: 3787

Group type: COMPARATOR
Intervention: Residual congestion at discharge (CCS of 1 or more)
Number of subjects: 3787

Group type: COMPARATOR
Intervention: Complete decongestion at discharge (CCS of 0)
Number of subjects: 3787
Study: 36690181

Group type: EXPERIMENTAL
Intervention: Cold soda water solution
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Any-temperature glucose solution containing a tea bag
Number of subjects: 399

Group type: COMPARATOR
Intervention: Room-temperature water-based glucose solution
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Glucose formula
Number of subjects: 399
Study: 36690388

Group type: EXPERIMENTAL
Intervention: Anifrolumab
Number of subjects: 819

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 819
Study: 36690404

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) infusion at a rate of 0.4 µg/kg/hour until surgical haemostasis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) infusion
Number of subjects: 0
Study: 36690406

Group type: EXPERIMENTAL
Intervention: Letermovir treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 36690415

Group type: EXPERIMENTAL
Intervention: IO-palliative care nurse training programme
Number of subjects: 24
Study: 36690538

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 60
Study: 36690550

Group type: EXPERIMENTAL
Intervention: DGAT2 inhibitor ervogastat (PF-06865571)
Number of subjects: 0

Group type: COMPARATOR
Intervention: DGAT1 inhibitor PF-04620110
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36690561

Group type: EXPERIMENTAL
Intervention: DTaP/IPV
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (no DTaP/IPV)
Number of subjects: 132
Study: 36690571

Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg
Number of subjects: 82
Study: 36690598

Group type: EXPERIMENTAL
Intervention: Infrared flashing light
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional technique (without infrared flashing light)
Number of subjects: 22
Study: 36690607

Group type: EXPERIMENTAL
Intervention: Activity-based locomotor training (ABLT)
Number of subjects: 7
Study: 36690734

Group type: EXPERIMENTAL
Intervention: Dexamethasone-sparing regimen with NEPA (netupitant/palonosetron fixed combination)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone-sparing regimen with NEPA
Number of subjects: 0
Study: 36690839

Group type: EXPERIMENTAL
Intervention: TMPRSS6-targeted therapy (specific intervention details not provided)
Number of subjects: 0
Study: 36690932

Group type: EXPERIMENTAL
Intervention: E/e' at 4 months adjusted for E/e' at hospitalization
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Change in E/e' between hospitalization and 4 months
Number of subjects: 267
Study: 36690940

Group type: EXPERIMENTAL
Intervention: Video-delivered mental health course based on cognitive behavioral techniques, no specific dosage or duration mentioned.
Number of subjects: 91
Study: 36690974

Group type: EXPERIMENTAL
Intervention: Interprofessional team training (4-h interdisciplinary training session based on psychological theories)
Number of subjects: 2865

Group type: EXPERIMENTAL
Intervention: Interprofessional team training
Number of subjects: 2865
Study: 36691000

Group type: EXPERIMENTAL
Intervention: Elective adhesiolysis
Number of subjects: 122

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Elective adhesiolysis (in patients with previous ASBO)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Non-operative treatment (in patients with previous ASBO)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Previous episodes of ASBO
Number of subjects: 122
Study: 36691039

Group type: EXPERIMENTAL
Intervention: Virtual reality-based cognitive behavioral therapy (VR-CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cognitive behavioral therapy (CBT)
Number of subjects: 0
Study: 36691060

Group type: EXPERIMENTAL
Intervention: Clinical Decision Aid Group (AI-powered clinical decision aid tool in addition to current practice)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control Group (current practice)
Number of subjects: 200
Study: 36691061

Group type: EXPERIMENTAL
Intervention: Nutrition counseling intervention group (IG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 120
Study: 36691082

Group type: EXPERIMENTAL
Intervention: Hemoadsorption (HA) with CytoSorb
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 21
Study: 36691103

Group type: EXPERIMENTAL
Intervention: Family Navigation (FN) + Usual Care
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 108
Study: 36691127

Group type: EXPERIMENTAL
Intervention: Chess-based cognitive remediation training (CB-CRT) as a therapy add-on for 6 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treatment as usual for AUD in a clinic
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treatment as usual for TUD outpatient treatment
Number of subjects: 96
Study: 36691129

Group type: EXPERIMENTAL
Intervention: Prefabricated contoured foot orthoses
Number of subjects: 28

Group type: COMPARATOR
Intervention: Flat shoe inserts (Control)
Number of subjects: 28
Study: 36691137

Group type: EXPERIMENTAL
Intervention: Er:YAG laser therapy with 'Latent inhibition' as anxiety-management technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rotary instruments with 'Latent inhibition' as anxiety-management technique
Number of subjects: 0
Study: 36691152

Group type: EXPERIMENTAL
Intervention: ODYSSEE-vCHAT via Internet-connected personal computer
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 162
Study: 36691157

Group type: EXPERIMENTAL
Intervention: Urgent endoscopy (within 6 hours after gastroenterological consultation)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Non-urgent endoscopy (between 6 hours and 24 hours after gastroenterological consultation)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Urgent endoscopy
Number of subjects: 400

Group type: COMPARATOR
Intervention: Non-urgent endoscopy
Number of subjects: 400
Study: 36691165

Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose administered approximately 3 months prior to TAVI
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo administered approximately 3 months prior to TAVI
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 36691167

Group type: EXPERIMENTAL
Intervention: Immediate and continuous heart rate feedback by dry electrode ECG
Number of subjects: 169

Group type: COMPARATOR
Intervention: Standard HR assessment (stethoscope, gel-electrode ECG, pulse oximetry)
Number of subjects: 169
Study: 36691183

Group type: EXPERIMENTAL
Intervention: Online mindfulness-based intervention (MBI) groups for mothers with PPDA and their partners, duration: 8 weeks
Number of subjects: 0
Study: 36691184

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Pre-chemotherapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Post-chemotherapy
Number of subjects: 37
Study: 36691193

Group type: EXPERIMENTAL
Intervention: Home visits intervention to improve access to tailored care
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Nominal Group Technique (NGT)
Number of subjects: 157
Study: 36691209

Group type: EXPERIMENTAL
Intervention: HCV self-testing (HCVST) delivered to the home via courier or peer delivery
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Standard-of-care HCV testing at testing sites (control)
Number of subjects: 1250
Study: 36691214

Group type: EXPERIMENTAL
Intervention: mpMR scan (annual for moderate/severe AIH patients)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: mpMR scan (three scans over 5 years for mild/moderate AIH patients)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: mpMR scan (increased frequency from 5 to 10 scans over 5 years for moderate/severe AIH patients)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: mpMR scan (increased frequency from 3 to 6 scans over 5 years for mild/moderate AIH patients)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: mpMR scan (5 scans replacing two biopsies over 5 years for all patients)
Number of subjects: 200
Study: 36691234

Group type: EXPERIMENTAL
Intervention: Distress measured by the Hopkins 25-item symptom checklist
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Inflammatory reactivity (IR) measured by multiplex assay after LPS challenge
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Persistent pain (PP) measured by the Brief Pain Inventory
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Induced secondary hyperalgesia (SH)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mediation analysis using baseline data from the PP group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Generalised mixed effects models analysis of IR and SH
Number of subjects: 100
Study: 36691248

Group type: EXPERIMENTAL
Intervention: Penicillin allergy assessment pathway
Number of subjects: 89

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 89
Study: 36691523

Group type: EXPERIMENTAL
Intervention: LAAC procedure using the WATCHMAN device with standard protocol (simple group)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: LAAC procedure with sheath depth less than device depth (complex group)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Re-ATP procedure
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Successful procedures after re-ATP
Number of subjects: 802
Study: 36691723

Group type: EXPERIMENTAL
Intervention: Interatrial shunt device (IASD) placement in patients with latent PVD
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Exercise stress
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CMR imaging
Number of subjects: 75
Study: 36691862

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation systems
Number of subjects: 0
Study: 36691880

Group type: EXPERIMENTAL
Intervention: Ostomy placement that meets international guidelines
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Optimal relationship with health professionals
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Proper knowledge and skills in ostomy care
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Colostomy
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Convex baseplate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Oval ostomy
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Independence in ostomy care
Number of subjects: 160
Study: 36691990

Group type: EXPERIMENTAL
Intervention: Bayesian quantile regression (BQR) model
Number of subjects: 1463
Study: 36692020

Group type: EXPERIMENTAL
Intervention: 200,000 IU cholecalciferol (vitamin D3)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 36692019

Group type: EXPERIMENTAL
Intervention: Delayed fractional (DFx) dosing schedule (0-1-6 month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly dosing schedule (0-1-2 month)
Number of subjects: 0
Study: 36692109

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery (RALS)
Number of subjects: 300
Study: 36692166

Group type: EXPERIMENTAL
Intervention: ANNE Sleep system
Number of subjects: 105
Study: 36692172

Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasound assessment of closure device deployment
Number of subjects: 650

Group type: COMPARATOR
Intervention: No intraoperative ultrasound assessment of closure device deployment
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Overall procedure
Number of subjects: 650
Study: 36692418

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg subcutaneously every 2 weeks
Number of subjects: 100
Study: 36692475

Group type: EXPERIMENTAL
Intervention: Polypharmacy (defined as the concurrent use of eight or more medications)
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: One or more major potential drug interactions (PDIs)
Number of subjects: 718
Study: 36692681

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 5578
Study: 36692682

Group type: EXPERIMENTAL
Intervention: One-time point SPECT imaging at 168 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Including a second time point SPECT imaging
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Single SPECT at 24 h or 48 h for organ dosimetry
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Planar scans for dosimetry
Number of subjects: 10
Study: 36692933

Group type: EXPERIMENTAL
Intervention: Young Melanoma Family Facebook Group
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Melanoma Family Healthy Lifestyle Facebook Group
Number of subjects: 1154

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1154
Study: 36692939

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VR-ET)
Number of subjects: 18
Study: 36692945

Group type: EXPERIMENTAL
Intervention: MiniMed 780G advanced hybrid closed-loop (AHCL) system
Number of subjects: 41

Group type: COMPARATOR
Intervention: MDI + SMBG (Control)
Number of subjects: 41
Study: 36692954

Group type: EXPERIMENTAL
Intervention: H1 coil (Deep TMS targeting the lateral prefrontal cortex)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: H7 coil (Deep TMS targeting the medial prefrontal cortex)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Both H1 and H7 coils
Number of subjects: 169
Study: 36693062

Group type: EXPERIMENTAL
Intervention: Gamified live feedback intervention (Intervention A) with instructions
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Gamified live feedback intervention (Intervention B) with instructions and a reward
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Gamified live feedback intervention (Intervention C) with instructions from the screen but no reward
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group with no screen activity
Number of subjects: 106
Study: 36693146

Group type: EXPERIMENTAL
Intervention: Simple aspiration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drainage
Number of subjects: 0
Study: 36693175

Group type: EXPERIMENTAL
Intervention: Palbociclib combined with letrozole or fulvestrant
Number of subjects: 51
Study: 36693400

Group type: EXPERIMENTAL
Intervention: Early mobilisation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 36693402

Group type: EXPERIMENTAL
Intervention: Continued enteral nutrition until extubation
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Fasting before extubation
Number of subjects: 1130
Study: 36693403

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 981

Group type: COMPARATOR
Intervention: Oxygen therapy (HFNO or standard oxygen)
Number of subjects: 981
Study: 36693401

Group type: EXPERIMENTAL
Intervention: Separation attempts from mechanical ventilation
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Successful weaning from mechanical ventilation
Number of subjects: 5869

Group type: COMPARATOR
Intervention: Transfer before separation attempt
Number of subjects: 5869

Group type: COMPARATOR
Intervention: Transfer after separation attempt
Number of subjects: 5869

Group type: COMPARATOR
Intervention: Death while invasively ventilated
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Delay in initiating first separation attempt
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Short wean (≤1 day)
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Intermediate weaning (2-6 days)
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Prolonged weaning (≥7 days)
Number of subjects: 5869

Group type: EXPERIMENTAL
Intervention: Weaning failure
Number of subjects: 5869

Group type: COMPARATOR
Intervention: Death in the intensive care unit
Number of subjects: 5869

Group type: COMPARATOR
Intervention: Death in hospital
Number of subjects: 5869
Study: 36693589

Group type: EXPERIMENTAL
Intervention: ACT+MBRP (Acceptance and Commitment Therapy + Mindfulness-Based Relapse Prevention)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Education control condition
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ACT+MBRP
Number of subjects: 160
Study: 36693654

Group type: EXPERIMENTAL
Intervention: Near infrared spectroscopy plus standard care
Number of subjects: 607

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 607
Study: 36693686

Group type: EXPERIMENTAL
Intervention: Previous calf IMI frequency
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Hamstring IMI frequency
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Most recent hamstring IMI >12 months but <3 years prior to PHE
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Age (per 1-year increase)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Most recent previous hamstring IMI >12 months but <3 years prior to PHE (multivariable analysis)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Age (multivariable analysis, per 1-year increase)
Number of subjects: 134
Study: 36693691

Group type: EXPERIMENTAL
Intervention: Live group (seated, virtual exercise programme via Zoom)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prercorded group (exercise using prerecorded videos)
Number of subjects: 60
Study: 36693722

Group type: EXPERIMENTAL
Intervention: Lower estimated glomerular filtration rate (eGFR)
Number of subjects: 3033

Group type: EXPERIMENTAL
Intervention: Cognitive function assessment using Mini-Mental State Examination (MMSE)
Number of subjects: 3033

Group type: EXPERIMENTAL
Intervention: Cox proportional hazard model for incident cognitive outcome
Number of subjects: 3033
Study: 36693773

Group type: EXPERIMENTAL
Intervention: Dexamethasone mouthwash (preventive)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo mouthwash (therapeutic)
Number of subjects: 39
Study: 36693948

Group type: EXPERIMENTAL
Intervention: Energy device for mesoappendix transection
Number of subjects: 3768

Group type: COMPARATOR
Intervention: Electrocautery for mesoappendix transection
Number of subjects: 3768

Group type: COMPARATOR
Intervention: Looped ligatures for appendix resection
Number of subjects: 3768

Group type: COMPARATOR
Intervention: Stapler for appendix resection
Number of subjects: 3768

Group type: COMPARATOR
Intervention: Clips for appendix resection
Number of subjects: 3768
Study: 36693978

Group type: EXPERIMENTAL
Intervention: Recruitment maneuver
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 20

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 20
Study: 36694110

Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach to evaluate post-COVID-19 conditions (PCC)
Number of subjects: 361
Study: 36694217

Group type: EXPERIMENTAL
Intervention: Conscious connected breathing with breath retention intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Deep breathing sham control intervention
Number of subjects: 24
Study: 36694232

Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services (PharmaCAP trial intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual standard care (control group)
Number of subjects: 0
Study: 36694238

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: GCS < 8
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Night time admission
Number of subjects: 630
Study: 36694361

Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Velpatasvir for 12 weeks
Number of subjects: 400
Study: 36694376

Group type: EXPERIMENTAL
Intervention: In-person ILI delivered by nutrition interns
Number of subjects: 268
Study: 36694613

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) followed by steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) followed by anakinra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) followed by infliximab
Number of subjects: 0
Study: 36694918

Group type: EXPERIMENTAL
Intervention: Culturally adapted telephone genetic counseling protocol and visual aid booklet
Number of subjects: 14
Study: 36694943

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic resonance-guided focused ultrasound (MRgFUS)
Number of subjects: 9
Study: 36695071

Group type: EXPERIMENTAL
Intervention: Aβ-PET in regions of WMH
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Aβ-PET in normal-appearing WM
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 115
Study: 36695286

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (pharmacological therapy only)
Number of subjects: 60
Study: 36695297

Group type: EXPERIMENTAL
Intervention: Full Support (with support from quality improvement expert)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Self-Guided (using only online materials)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual Care (nonrandomized control arm)
Number of subjects: 24
Study: 36695299

Group type: EXPERIMENTAL
Intervention: Obesity clinic group (BMI >90th percentile)
Number of subjects: 3854

Group type: COMPARATOR
Intervention: Population-based group
Number of subjects: 3854
Study: 36695307

Group type: EXPERIMENTAL
Intervention: Cardiac diastolic dysfunction
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Overt coronary microvascular dysfunction (CMD)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Overt CMD
Number of subjects: 330
Study: 36695396

Group type: EXPERIMENTAL
Intervention: Intermediate-dose LMWH
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Low-dose LMWH
Number of subjects: 1110